EDP Sciences logo
Search
Menu
All issues Volume 38 / No 2 (March-April 2007) Vet. Res., 38 2 (2007) 229-241 References
Open Access
Issue
Vet. Res.
Volume 38, Number 2, March-April 2007
Respiratory viruses of domestic animals
Page(s) 229 - 241
DOI https://doi.org/10.1051/vetres:200661
Published online 25 January 2007
How to cite this article Vet. Res. (2007) 229-241
References of  Vet. Res. 38 (2007) 229-241
  1. Akkermans J.P., Aujeszky's disease in the Netherlands, Pig Vet. Soc. Proc. (1980) 5:59-67.
  2. Aujeszky A., Ueber eine neue Infektionskrankheit bei Haustieren, Zbl. Bakteriol. Infektionskrankh. Parasitenkde. 1. Abt. Orig. (1902) 32:353-357.
  3. Baskerville A., The histopathology of pneumonia produced by aerosol infection of pigs with a strain of Aujeszky's disease virus, Res. Vet. Sci. (1971) 12:590-592 [PubMed].
  4. Ben-Porat T., Kaplan A.S., Molecular biology of pseudorabies virus, in: Roizman B. (Ed.), The Herpesviruses, Plenum press, 1985, Vol. 3, pp. 105-173.
  5. Berthomme H., Monahan S.J., Parris D.S., Jacquemont B., Epstein A.L., Cloning, sequencing and functional characterization of the two subunits of the pseudorabies virus DNA polymerase holoenzyme: evidence for specificity of interaction, J. Virol. (1995) 69:2811-2818 [PubMed].
  6. Bitsch V., Correlation between the pathogenicity of field strains of Aujeszky's disease virus and their ability to cause cell fusion - syncytia formation - in cell cultures, Acta Vet. Scand. (1980) 21:708-710 [PubMed].
  7. Brideau A.D., Banfield B.W., Enquist L.W., The Us9 gene product of pseudorabies virus, an alphaherpesvirus, is a phosphorylated tail-anchored type II membrane protein, J. Virol. (1998) 72:4560-4570 [PubMed].
  8. Chang Y.Y., Lin H.W., Wong M.L., Chang T.J., Regulation of the vhs gene promoter of pseudorabies virus by IE180 and EP0, and the requirement of a Sp1 site for the promoter function, Virus Genes (2004) 28:247-258 [CrossRef] [PubMed].
  9. De Wind N., Berns J., Gielkens A.L., Kimman T.G., Ribonucleotide reductase-deficient mutants of pseudorabies virus are avirulent for pigs and induce partial protective immunity, J. Gen. Virol. (1993) 74:351-359 [PubMed].
  10. Elford W.J., Galloway I.A., The size of the virus of Aujeszky's disease ("pseudo-rabies", "infectious bulbar paralysis", "mad itch") by ultrafiltration analysis, J. Hyg. (Cambr.) (1936) 36:536-539.
  11. Favoreel H.W., Nauwynck H.J., Halewyck H.M., Van Oostveldt P., Mettenleiter T.C., Pensaert M.B., Antibody-induced endocytosis of viral glycoproteins and major histocompatibility complex class I on pseudorabies virus-infected monocytes, J. Gen. Virol. (1999) 80:1283-1291 [PubMed].
  12. Favoreel H.W., Van Minnebruggen G., Adriaensen D., Nauwynck H.J., Cytoskeletal rearrangements and cell extensions induced by the US3 kinase of an alphaherpesvirus are associated with enhanced spread, Proc. Natl. Acad. Sci. USA (2005) 102:8990-8995 [CrossRef] [PubMed].
  13. Fuchs W., Granzow B.G., Klupp B.G., Kopp M., Mettenleiter T.C., The UL48 tegument protein of pseudorabies virus is critical for intracytoplasmic assembly of infectious virus, J. Virol. (2002) 76:6729-6742 [CrossRef] [PubMed].
  14. Fuchs W., Klupp B.G., Granzow H., Osterrieder N., Mettenleiter T.C., The interacting UL31 and UL34 gene products of pseudorabies virus are involved in egress from the host-cell nucleus and represent components of primary enveloped but not of mature virions, J. Virol. (2002) 76:364-378 [CrossRef] [PubMed].
  15. Fuchs W., Klupp B.G., Granzow H., Hengartner C., Brack A., Mundt A., Mettenleiter T.C., Physical interaction between envelope glycoproteins E and M of pseudorabies virus and the major tegument protein UL49, J. Virol. (2002) 76:8208-8217 [CrossRef] [PubMed].
  16. Fuchs W., Klupp B.G., Granzow H., Mettenleiter T.C., Essential function of the pseudorabies virus UL36 gene product is independent of its interaction with the UL37 protein, J. Virol. (2004) 78:11879-11889 [CrossRef] [PubMed].
  17. Hanson R.P., The history of pseudorabies in the United States, J. Am. Vet. Med. Assoc. (1954) 124:259-261 [PubMed].
  18. Hanssens F.P., Nauwynck H.J., Pensaert M.B., Involvement of membrane-bound viral glycoproteins in adhesion of pseudorabies virus-infected cells, J. Virol. (1993) 67:4492-4496 [PubMed].
  19. Iglesias G., Pijoan C., Molitor T., Interactions of pseudorabies virus with swine alveolar macrophages I: virus replication, Arch. Virol. (1989) 104:107-115 [CrossRef] [PubMed].
  20. Jöns A., Gerdts V., Lange E., Kaden V., Mettenleiter T.C., Attenuation of dUTPase deficient pseudorabies virus for the natural host, Vet. Microbiol. (1997) 56:47-54 [CrossRef] [PubMed].
  21. Kaplan A.S., Vatter A.E., A comparison of herpes simplex and pseudorabies viruses, Virology (1959) 7:394-407 [CrossRef] [PubMed].
  22. Kaliman A.V., Boldogkoi Z., Fodor I., Large and small subunits of the Aujeszky's disease virus ribonucleotide reductase: nucleotide sequence and putative structure, Biochim. Biophys. Acta (1994) 1219:151-156 [PubMed].
  23. Kimman T.G., Pol J.M., de Wind N., Oei-Lie N., Berns A.J., Gielkens A.L., Role of different genes in the virulence and pathogenesis of Aujeszky's disease virus, Vet. Microbiol. (1992) 33:45-52 [CrossRef] [PubMed].
  24. Kimman T.G., Immunological protection against pseudorabies virus, in: Aujeszky's disease, Proceedings of OIE Symposium, Bangkok, Thailand, 1994, pp. 11-22.
  25. Kit S., Kit M., Bartkoski M.J., Dees G., Genetically engineered pseudorabies virus vaccine with deletions in thymidine kinase and glycoprotein genes, Cold Spring Harbor Symposium Vaccines 87, Pseudorabies Vaccines, 1987, pp. 345-349.
  26. Klupp B.G., Fuchs W., Weiland E., Mettenleiter T.C., Pseudorabies virus glycoprotein L is necessary for virus infectivity but dispensable for virion localization of glycoprotein H, J. Virol. (1997) 71:7687-7695 [PubMed].
  27. Klupp B.G., Fuchs W., Granzow H., Nixdorf R., Mettenleiter T.C., The pseudorabies virus UL36 tegument protein physically interacts with the UL37 protein, J. Virol. (2002) 76:3065-3071 [CrossRef] [PubMed].
  28. Klupp B.G., Hengartner C.J., Mettenleiter T.C., Enquist L.W., Complete, annotated sequence of the pseudorabies virus genome, J. Virol. (2004) 78:424-440 [CrossRef] [PubMed].
  29. Klupp B.G., Altenschmidt J., Granzow H., Fuchs W., Mettenleiter T.C., Identification and characterization of the pseudorabies virus UL43 protein, Virology (2005) 334:224-233 [CrossRef] [PubMed].
  30. Köhler M., Köhler W., Zentralblatt für Bakteriologie - 100 years ago Aladar Aujeszky detects a "new" disease - or: It was the cow and not the sow, Int. J. Med. Microbiol. (2003) 292:423-427 [CrossRef] [PubMed].
  31. Kritas S.K., Pensaert M.B., Mettenleiter T.C., Role of envelope glycoproteins gI, gp63 and gIII in the invasion and spread of Aujeszky's disease virus in the maxillary nerve and trigeminal ganglion of pigs after intranasal inoculation, J. Gen. Virol. (1994) 76:2063-2066.
  32. Kritas S.K., Pensaert M.B., Mettenleiter T.C., Invasion and spread of single glycoprotein deleted mutants of Aujesky's disease virus (PRV) in the trigeminal nervous pathway of pigs after intranasal inoculation, Vet. Microbiol. (1994) 40:323-334 [CrossRef] [PubMed].
  33. Lehman I.R., Boehmer P.E., Replication of herpes simplex virus DNA, J. Biol. Chem. (1999) 274:28059-28062 [CrossRef] [PubMed].
  34. McFerran J.B., Dow C., The excretion of Aujeszky's disease virus by experimentally infected pigs, Res. Vet. Sci. (1964) 5:405-410.
  35. Mettenleiter T.C., Zsak L., Zuckermann F., Sugg N., Kern H., Ben-Porat T., Interaction of glycoprotein gIII with a cellular heparinlike substance mediates adsorption of pseudorabies virus, J. Virol. (1990) 64:278-286 [PubMed].
  36. Mettenleiter T.C., Aujeszky's disease (pseudorabies) virus: the virus and molecular pathogenesis - State of the art, June 1999, Vet. Res. (2000) 31:99-115 [PubMed] [EDP Sciences].
  37. Mettenleiter T.C., Brief overview on cellular virus receptors, Virus Res. (2002) 82:3-8 [CrossRef] [PubMed].
  38. Mettenleiter T.C., Intriguing interplay between viral proteins during herpesvirus assembly or not: The herpesvirus assembly puzzle, Vet. Microbiol. (2006) 113:163-169 [CrossRef] [PubMed].
  39. Miry C., Pensaert M., Aujeszky's disease replication in tonsils and respiratory tract of non-immune and immune pigs, in: van Oirschot J.T. (Ed.), Vaccination and control of Aujeszky's disease, 1989, pp. 163-173.
  40. Mulder W., Pol J., Kimman T., Kok G., Priem J., Peeters B., Glycoprotein D-negative pseudorabies virus can spread transneuronally via direct neuron-to-neuron transmission in its natural host, the pig, but not after additional inactivation of gE or gI, J. Virol. (1996) 70:2191-2200 [PubMed].
  41. Nauwynck H.J., Pensaert M.B., Abortion induced by cell-associated pseudorabies virus in vaccinated sows, Am. J. Vet. Res. (1992) 53:489-493 [PubMed].
  42. Nauwynck H.J., The cell-associated spread of Aujeszky's disease virus and its possible role in the pathogenesis of abortion in vaccinated sows, Ph.D. thesis, Ghent University, Belgium, 1993.
  43. Nauwynck H.J., Pensaert M.B., Cell-free and cell-associated viremia in pigs after oronasal infection with Aujeszky's disease virus, Vet. Microbiol. (1995) 43:307-314 [CrossRef] [PubMed].
  44. Newcomb W.N., Homa F.L., Thomsen D.R., Trus B.L., Cheng N., Steven A., Booy F., Brown J.C., Assembly of the herpes simplex virus procapsid from purified components and identification of small complexes containing the major capsid and scaffolding proteins, J. Virol. (1999) 73:4239-4250 [PubMed].
  45. Ono E., Watanabe S., Nikami H., Tasaki T., Kida H., Pseudorabies virus (PrV) early protein 0 activates PrV gene transcription in combination with the immediate-early protein IE180 and enhances the infectivity of PrV genomic DNA, Vet. Microbiol. (1998) 63:99-107 [CrossRef] [PubMed].
  46. Ou C.J., Wong M.L., Chang T.J., A TEF-1-element is required for activation of the promoter of pseudorabies virus glycoprotein X gene by IE180, Virus Genes (2002) 25:241-253 [CrossRef] [PubMed].
  47. Pensaert M.B., Miry C., Biront P., Castryck F., De Roose P., Robijns J., Segers E., Evolution of Aujeszky's disease in Belgium (1974-1987), Flemish Vet. J. (1987) 56:425-432.
  48. Pensaert M.B., De Smet K., De Waele K., Extent and duration of virulent virus excretion upon challenge of pigs vaccinated with different glycoprotein-deleted Aujeszky's disease vaccines, Vet. Microbiol. (1990) 22:107-117 [CrossRef] [PubMed].
  49. Pensaert M.B., Labarque G., Favoreel H., Nauwynck H., Aujeszky's disease vaccination and differentiation of vaccinated from infected pigs, Dev. Biol. (Basel) (2004) 119:243-254 [PubMed].
  50. Pittler M., The occurrence and control of Aujeszky's disease in the Federal Republic of Germany, in: Wittmann G., Hall S.A. (Eds.), Current topics in veterinary medicine and animal science, Martinus Nijhoff, vol. 17, 1982, pp. 259-265.
  51. Pol J.M.A., Gielkens A.L.J., van Oirschot J.T., Comparative pathogenesis of three strains of pseudorabies virus in pigs, Microb. Pathog. (1989) 7:361-371 [PubMed].
  52. Pol J.M., Broekhuysen-Davies J.M., Wagenaar F., La Bonnardière C., The influence of porcine recombinant interferon-alpha 1 on pseudorabies virus infection of porcine nasal mucosa in vitro, J. Gen. Virol. (1991) 72:933-938 [PubMed].
  53. Rauh I., Mettenleiter T.C., Pseudorabies virus glycoproteins gII and gp50 are essential for virus penetration, J. Virol. (1991) 65:5348-5356 [PubMed].
  54. Reagan R.L., Schenk D.M., Harmon M.P., Brueckner A.L., Morphological observations by electron microscopy of pseudorabies virus (Aujeszky strain) after propagation in the rabbit, Am. J. Vet. Res. (1952) 13:577-578 [PubMed].
  55. Sabin A.B., Studies on the B virus. I. The immunological identity of a virus isolated from a human case of ascending myelitis associated with visceral necrosis, Br. J. Exp. Pathol. (1934) 15:248-268.
  56. Sabo A., Rajcani J., Blaskovic D., Studies on the pathogenesis of Aujeszky's disease. I. Distribution of the virulent virus in piglets after peroral infection, Acta Virol. (1968) 12:214-221 [PubMed].
  57. Sabo A., Rajcani J., Blaskovic D., Studies on the pathogenesis of Aujeszky's disease. III. The distribution of virulent virus in piglets after intranasal infection, Acta Virol. (1969) 13:407-414 [PubMed].
  58. Schmiedhoffer J., Beiträge zur Pathologie der infektiösen Bulbär paralyse (Aujeszkyschen Krankheit), Z. Infekt. Krankh. Parasit. Hyg. Haustier (1910) 8:383-405.
  59. Schwartz J.A., Brittle E.E., Reynolds A.E., Enquist L.W., Silverstein S.J., UL54-null pseudorabies virus is attenuated in mice but productively infects cells in culture, J. Virol. (2006) 80:769-784 [CrossRef] [PubMed].
  60. Shope R.E., An experimental study of "mad itch" with especial reference to its relationship to pseudorabies, J. Exp. Med. (1931) 54:233-248 [CrossRef].
  61. Shope R.E., Pseudorabies is a contagious disease in swine, Science (1934) 80:102-103 [CrossRef].
  62. Smith G.A., Enquist L.W., Break ins and break outs: viral interaction with the cytoskeleton of mammalian cells, Annu. Rev. Cell Dev. Biol. (2002) 18:135-161 [PubMed].
  63. Spear P.G., Eisenberg R.J., Cohen G.H., Three classes of cell surface receptors for alphaherpesvirus entry, Virology (2000) 275:1-8 [CrossRef] [PubMed].
  64. Strebel M., Eine eigenthümliche Juckkrankheit beim Rinde, Schweiz. Arch. Tierheilk. (1889) 31:125-129.
  65. Taharaguchi S., Inoue H., Ono E., Kida H., Yamada S., Shimizu Y., Mapping of transcriptional regulatory domains of pseudorabies virus immediate-early protein, Arch. Virol. (1994) 137:289-302 [CrossRef] [PubMed].
  66. Toma B., Le Turdu Y., Ursache R., Bernard F., Rose R., David C., Metianu T., Renault L., Gilbert Y., Duée J.P., Épidémiologie descriptive de la maladie d'Aujeszky en France en 1977, Rec. Méd. Vét. (1985) 154:681-685.
  67. Van de Walle G.R., Favoreel H.W., Nauwynck H.J., Mettenleiter T.C., Pensaert M.B., Transmission of pseudorabies virus from immune-masked blood monocytes to endothelial cells, J. Gen. Virol. (2003) 84:629-637 [CrossRef] [PubMed].
  68. Van de Walle G.R., Favoreel H.W., Nauwynck H.J., Pensaert M.B., Antibody-induced internalization of viral glycoproteins and gE-gI Fc receptor activity protect pseudorabies virus-infected monocytes from efficient complement-mediated lysis, J. Gen. Virol. (2003) 84:939-947 [CrossRef] [PubMed].
  69. Van Minnebruggen G., Favoreel H.W., Jacobs L., Nauwynck H.J., Pseudorabies virus US3 protein kinase mediates actin stress fiber breakdown, J. Virol. (2003) 77:9074-9080 [CrossRef] [PubMed].
  70. Vannier P., Hutet E., Bourgueil E., Cariolet R., Level of virulent virus excreted by infected pigs previously vaccinated with different glycoprotein deleted Aujeszky's disease vaccines, Vet. Microbiol. (1991) 29:213-223 [CrossRef] [PubMed].
  71. Van Oirschot J.T., Kaashoek M.J., Rijsewijk F.A., Stegeman J.A., The use of marker vaccines in eradication of herpesviruses, J. Biotechnol. (1996) 44:75-81 [CrossRef] [PubMed].
  72. Wittmann G., Jakubik J., Ahl R., Multiplication and distribution of Aujeszky's disease (pseudorabies) virus in vaccinated and non-vaccinated pigs after intranasal infection, Arch. Virol. (1980) 66:227-240 [CrossRef] [PubMed].
  73. Wong M.L., Ho T.Y., Huang J.H., Hsiang C.Y., Chang T.J., Stimulation of type I DNA topoisomerase gene expression by pseudorabies virus, Arch. Virol. (1997) 142:2099-2105 [CrossRef] [PubMed].
  74. Wu L., Berk A.J., Transcriptional activation by the pseudorabies virus immediate early protein requires the TATA box element in the adenovirus 2 E1B promoter, Virology (1988) 167:318-322 [CrossRef] [PubMed].